Internal Medicine, Hematology & Oncology · Springfield, IL
NPI
1881637049
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
900 N 1st Street
Springfield, IL, 62702
Phone (217) 528-7541
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
152,816 services
Medicare patients, 2024
610
Average age 74
Drug cost, 2024
$6.8M
2,811 prescriptions
Company payments, 2025
$181
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Namita Vinayek was code J1756 (injection, iron sucrose, 1 mg), 22,200 times for 54 patients. In total Namita Vinayek billed 152,816 services in 138 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 22,200 | 54 | $0.17 | $3,822 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 15,600 | 25 | $44.61 | $696K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 14,280 | 19 | $0.26 | $3,775 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,900 | 18 | $0.11 | $757 |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,795 | 12 | $0.08 | $461 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,846 | 63 | $0.09 | $254 |
| J0897 Injection, denosumab, 1 mg | Office | 2,820 | 19 | $20.61 | $58K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,460 | 45 | $0.67 | $978 |
| 99214 Office E&M - Established | Office | 964 | 382 | $90.82 | $88K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 860 | 14 | $0.26 | $221 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 846 | 142 | $0.51 | $429 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 806 | 13 | $3.52 | $2,841 |
| 36415 Venipuncture Blood Collection | Office | 563 | 267 | $8.20 | $4,618 |
| 85025 Blood Count | Office | 560 | 179 | $7.61 | $4,262 |
| J9190 Injection, fluorouracil, 500 mg | Office | 555 | 17 | $2.20 | $1,222 |
By year: 2022 $2.7M for 159,770 services; 2023 $2.5M for 142,201 services; 2024 $2.3M for 152,816 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 563 | 267 | $8.20 | $4,618 |
| 85025 Blood Count | 560 | 179 | $7.61 | $4,262 |
| 80047 Clinical Chemistry | 360 | 73 | $13.46 | $4,846 |
Medicare prescription drug claims, 2024
In 2024, the drug Namita Vinayek prescribed most often to Medicare patients was Anastrozole, with 713 prescriptions and refills. In total Namita Vinayek wrote 2,811 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 713 | 1,858 | 206 | $11K |
| Eliquis Apixaban | 164 | 212 | 27 | $123K |
| Tamoxifen Citrate Generic | 140 | 381 | 41 | $2,387 |
| Gabapentin Generic | 101 | 118 | 28 | $617 |
| Ondansetron Hcl Generic | 83 | 83 | 47 | $1,178 |
| Dexamethasone Generic | 81 | 86 | 21 | $564 |
| Alendronate Sodium Generic | 80 | 206 | 25 | $391 |
| Ibandronate Sodium Generic | 79 | 235 | 25 | $2,266 |
| Prochlorperazine Maleate Generic | 74 | 74 | 45 | $670 |
| Lorazepam Generic | 67 | 67 | 24 | $147 |
| Hydroxyurea Generic | 65 | 111 | 16 | $1,454 |
| Acyclovir Generic | 58 | 75 | Under 11 | $459 |
| Ibrance Palbociclib | 55 | 55 | Under 11 | $860K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 54 | 54 | 20 | $627 |
| Prednisone Generic | 46 | 60 | 22 | $223 |
Brand drugs: 570 claims; generic drugs: 2,241 claims; opioid claims: 108.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Namita Vinayek $181 ($181 in general payments such as food, travel and fees) from 7 companies. The largest payer was Novartis Pharmaceuticals Corporation with $54.85.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.